The papers which compose this book deal almost exclusively with reported observations on a new muscle-relaxing, pain-relieving agent called Carisoprodol 350 mg .
The pharmacology and clinical studies included cover a wide range of disciplines and observations, including use of the Soma drug in inflammatory and neurological disorders. In general, carisoprodol exhibits some of the properties of its predecessors, mephenesin and meprobamate. The point that the reports are of a preliminary character is emphasized in a summary of the conference that appears with a general index at the end. Some of the papers are followed by references and discussions. These features should increase the value of the book for those who have a particular interest in skeletal muscle relaxants and their use as tranquilizers.